Table 1

Patient demographics and baseline tumor characteristics

Anastrozole
1 mg/day (n = 12)10 mg/day (n = 12)
Age (yr)a74.1 ± 8.768.8 ± 8.9
Weight (kg)a69.6 ± 9.677.5 ± 14.2
Height (cm)a156.3 ± 12.2157.8 ± 11.7
Tumor stageb
T211(91.7)10(83.3)
T3 0 (0) 2(16.7)
T4B 1 (8.3) 0 (0)
Lymph node metastases 2(16.7) 1 (8.3)
Tumor volume assessment (cm3)
Caliper
Median23.7 27.3
Maximum42.4161.0
Minimum12.4 10.9
Ultrasound
Median 4.8  4.9
Maximum 9.9 14.3
Minimum 2.4  1.4
Mammography
Median 7.3  8.4
Maximum25.5 47.7
Minimum 1.4  0.7
  • a Mean ± SD.

  • b No. of patients, with percentage in parens.